Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Chalkstone Avenue
Prior 4
Providence, RI 02908Phone+1 401-456-5312Fax+1 401-456-6708- Is this information wrong?
Summary
- Dr. Steven Katz is a surgical oncologist in Providence, RI and is affiliated with Women & Infants Hospital of Rhode Island and Roger Williams Medical Center. He received his medical degree from NYU School of Medicine and has been in practice 17 years. He also speaks multiple languages, including Hebrew. He specializes in hepatobiliary surgery, melanoma, and soft tissue sarcoma. He runs a translational immunotherapy program, having led five solid tumor CAR-T clinical trials and oversees cGMP cell therapy manufacturing. Dr. Katz recently joined TriSalus Life Sciences as the Chief Medical Officer and continues to practice surgical oncology in selected indications.
Education & Training
- Memorial Sloan-Kettering2009
- NYU Grossman School of MedicineResidency, Surgery, 2007
- NYU Grossman School of MedicineInternship, Surgery, 2000 - 2001
- New York University School of MedicineClass of 2000
Certifications & Licensure
- RI State Medical License 2009 - 2024
- NY State Medical License 2001 - 2016
- OH State Medical License 2008 - 2009
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells Start of enrollment: 2011 Jun 01
- CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases Start of enrollment: 2015 Apr 01
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer Start of enrollment: 2017 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model.Benedict A Capacio, Jayanth S Shankara Narayanan, Diego A Vicente, Yujia Liu, Jason P LaPorte, Bryan F Cox, David B Jaroch, Steven C Katz, Rebekah R White> ;Surgery. 2023 Sep 1
- Novel treatment paradigms for metastatic uveal melanoma.Sapna P Patel, Steven C Katz> ;Cancer Gene Therapy. 2022 Dec 1
- 4 citationsAntigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis Model.Louis F Chai, John C Hardaway, Kara R Heatherton, Kyle P O'Connell, Jason P LaPorte, Prajna Guha, Mikayla C Lopes, Benjamin A Rabinowitz, David Jaroch, Bryan F Cox, Ro...> ;The Journal of Surgical Research. 2022 Apr 1
- Join now to see all
Journal Articles
- STAT3 Inhibition Induces Bax-Dependent Apoptosis in Liver Tumor Myeloid-Derived Suppressor CellsGeorge Miller, N Joseph Espat, Steven C Katz, Nature
Press Mentions
- TriSalus Hires Katz to Run Studies of Ex-Dynavax Cancer DrugSeptember 29th, 2020
- High-Pressure Application Breakthrough Aids RWMC’s Immunotherapy AmbitionsDecember 21st, 2018
- Rare Disease Day 2024: A Live Panel Discussion with Dr. Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree SeetharamuMarch 19th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society of Immunotherapy for CancerMember
- Member
- Society of University SurgeonsMember
- Member
Other Languages
- Hebrew
Hospital Affiliations
- Women & Infants Hospital of Rhode IslandProvidence, Rhode Island
- Roger Williams Medical CenterProvidence, Rhode Island
External Links
- Roger Williams Surgical Oncology http://www.rhodeislandcancer.org
- RWMC Clinical Trialshttp://www.rhodeislandcancer.org/Services/ClinicalTrials/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: